More than 40 million Americans suffer needlessly in chronic pain

because 20 million Americans abuse prescription opioids.



Pharmacy Diversion Mitigation Specialists
PPPFD, Inc. Business Plan© PPPFD, Inc. provides pharmacists with exceedingly effective controls against Rx drug diversion. PROBLEM: Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. In 2008, more than 36,000 people died from drug overdoses, and most of these deaths were caused by prescription drugs according to the U.S. Centers for Disease Control. As a result of Congressional pressure, USDOJ/DEA has targeted wholesalers and pharmacies with extensive investigations. Massive fines against wholesalers and pharmacies (McKesson $13M; Cardinal $34M; Walgreens $80M) have severely constricted the supply of important medicines to legitimate patients. NATIONAL TRAVESTY: Millions of Americans suffer needlessly because pharmacists feel dispensing controlled substance medicine is “too risky” considering the current DEA focus on pharmacies. VULNERABILITY: Pharmacists need protection from the dangers and risks of dispensing controlled substance medicine so that legitimate patients can have access to these important medicines. SOLUTION: PPPFD, Inc. provides pharmacists with ongoing Diversion Mitigation services that verify the legitimacy of patients receiving controlled substances and also verify the legitimacy of their physicians. PPPFD employs a BioMatrix™ of forensic technologies to help screen out fraudulent patients, verify prescription legitimacy, monitor patients (and physicians) in the clinic & community, and actually STOPS prescription drug diversion. Here are the features: 1. New Patient Pre-Screen: All New Patients are enrolled into BioMatrix Registry™ (HIPAA compliant) - the nation’s first instant, real-time, nationwide, and biometrics protected prescription and patient monitoring system. New Patients must also pass a Pre-Screening Session consisting of a Drug Test, a national Criminal Background History Report, a pain disability assessment, a substance abuse history, a State Prescription Monitoring Program report (when available), and qualified patient candidates for controlled substance therapy are stratified into Diversion Risk Categories of either: Low, Moderate, or High for drug and pill count tests. Low Risk Patients are tested at least semiannually. Medium Risk Patients are tested at least quarterly. High Risk Patients are tested at least monthly. 2. Verify Prescription Legitimacy: Pharmacists are provided a PPPFD verified pain assessment and diversion mitigation compliance report. A PPPFD audit is also conducted to ensure the patient chart contains minimum documentation such as: radiology/lab reports, history, and exam (pharmacists will soon view History Present Illness and Diagnosis Reports in BioMatrix). DNA testing is available to validate high dose patients as poor metabolizers of opiate medicines. Voice recognition technology is also available to validate patient veracity during Risk Stratification Interviews. 3. Monitor Compliance: BioMatrix Registry tracks prescriptions (even across state lines) to the pharmacy designated in the Physician Treatment Agreement and also helps ensure all chronic non-controlled medicines are filled by the pharmacy dispensing the controlled substance medicines. This enables the pharmacist to more effectively monitor and prevent drug to drug interactions! PPPFD Auditors (former narcotics detectives) conduct random and risk stratified frequency based pill counts in the clinic or pharmacy between office visits and in the community to verify patient compliance. 4. STOPS Diversion: Field Auditors also conduct diversion intelligence gathering activities through community based surveillance efforts such as offering cash Rewards for “anonymous tips.” Auditors also gather evidence, press charges and provide court testimony on patients diverting pharmacy dispensed medicine. BioMatrix Registry™ provides the unprecedented ability to “blacklist” non-compliant patients and stop them from obtaining pills from any pharmacy protected by PPPFD, Inc. HOW IT WORKS IN THE PHARMACY: Whenever patients present controlled substance prescriptions at the pharmacy counter, pharmacists will simply instruct patients to scan their fingerprints into the BioMatrix Registry (equipment & software provided by PPPFD to Diversion Mitigation Pharmacies free of charge). The patient picture, profile, and prescription verification reports will display on the pharmacy computer screen. The pharmacist will have instant verification of the patients’ picture taken at the clinic, Government Issued Identification card information, address, and phone number(s). BioMatrix Registry will also enable the pharmacist to verify the paper prescriptions presented by the patient by looking at the prescriptions entered by the clinic staff into the patient’s BioMatrix profile. A soon to be released BioMatrix software upgrade will enable the pharmacist to view the Patient’s Comprehensive History of Present Illness, physician diagnosis, and National Criminal History Report. The pharmacist also may “flag” any patient for a drug test and pill count to be conducted in the patient’s home by a PPPFD Field Auditor whenever the patient displays any high risk behavior or clues in the pharmacy. The pharmacist will also have a direct cell phone number to a PPPFD Auditor in the physician office if more information is necessary to verify legitimacy of the prescriptions. If the patient is not enrolled in the BioMatrix Registry (and has not been Black Listed in BioMatrix for prior diversion activities), a Narcotics Auditor at the pharmacy (or a central location near the pharmacy) will screen and enroll the patient into BioMatrix Registry for ongoing verification monitoring in the clinic and community. LEGAL CONSIDERATIONS: Patient information is protected according to the HIPAA Act. Additionally, to protect pharmacists from HIPAA, four safeguard methods are employed that includes: all patients will sign the PPPFD Pharmacy Diversion Mitigation Agreement granting HIPAA waivers to the Pharmacist and PPPFD in order to "help fight diversion"; patients agree (in writing) HIPAA does NOT protect criminal activity; PPPFD is the investigating agency that will press charges (not the pharmacist) against criminal patients and as such PPPFD is a non-covered HIPAA entity (immune from HIPAA) because we do NOT bill insurances; PPPFD works closely with law enforcement and (in order to preclude useless HIPAA complaints) we press charges against fraudulent patients ONLY when the prosecutor AGREES the case is prosecutable. Additionally, HIPAA does NOT prohibit fraudulent patients from being Black Listed in BioMatrix as a result of their fraudulent activity. The BioMatrix Black List keeps fraudulent patients OUT of PPPFD pharmacies! Law enforcement agencies including police, narcotics detectives, Sheriffs, State Police, and prosecutors in West Virginia, Kentucky, and Virginia have signed a petition supporting adoption of PPPFD technology. BioMatrix was referred to as “…exciting technology” by a DEA Office of Diversion Control staffer in Washington, DC and HHS OIG investigators commented, “I like it…” although neither are permitted to endorse PPPFD or related technology. DIVERSION MITIGATION COLLABORATION WITH PHYSICIANS: PPPFD informs all controlled substance high prescribers (prescribing to patients served by the pharmacy) of the Diversion Mitigation services provided to the physician’s practice by collaborating with the Diversion Mitigation Specialty Pharmacy. HOW TO BECOME A SPECIALTY PHARMACY: To become a Specialty Pharmacy, pharmacy owners must firmly agree (in writing) to NEVER dispense a narcotics prescription unless the patient has been pre-screen enrolled into the PPPFD BioMatrix Registry and verified each month by a PPPFD Narcotics Auditor. How? Pharmacy owners and PICs sign a Diversion Mitigation Collaborative Agreement with PPPFD, Inc. CLINICAL EXPERIENCE: During R&D, PPPFD conducted 2,212 Patient Interview Screening Audits in six states. Research proved PPPFD technology: protects pharmacists; detects and STOPS physician diversion; creates fraud deterrence that prevents diversion by patients; helps improve pain patient care; identifies and gains help for patients with substance use disorders; and prevents healthcare fraud, waste, and abuse. Verified patients benefit from appropriate pharmacy access to legitimate medications while criminal patients are deterred. Law-abiding patients overwhelmingly endorsed PPPFD technology! PROVEN EFFECTIVENESS: As of October 1, 2013, PPPFD technology has screened out over 950 noncompliant pain medicine patients from an established patient population of 3,500 patients from six clinics in three states resulting in criminal prosecution of fraudulent patients or substance misuse discharges of patients from West Virginia, Virginia, Maryland, Pennsylvania, Ohio, Kentucky, Tennessee, North Carolina, South Carolina, Georgia, and Florida. PPPFD also “caught” a physician trading pills for sex and succeeded in helping revoke his medical license and his case is being prosecuted by the U.S. Attorney’s Office in Charleston, WV. COMMUNITY PROTECTION: Employs “experienced” Narcotics Detectives to conduct in-home patient “pill counts”, provide community surveillance, and investigate community diversion “tips”. WORLD HEALTH ORGANIZATION (WHO): PPPFD fully supports the WHO recommendation that controlled release drugs, such as OxyContin, be used only for Severe Pain. REGULATORY LIAISON: Establishes liaison with regulatory agencies at local, state, and federal levels to include: Board of Pharmacy; local police; State Police; and USDOJ/DEA. COMPANY: PPPFD, Inc is an alliance of Patients, Physicians, & Pharmacists Fighting Diversion of controlled substance medicines. Advisors during the R&D of our technology include: patients, physicians; pharmacists; psychologists, prosecutors; drug task force agents; state police; and Secret Service.





Printer Friendly

106 Lockheed Drive

P.O. Box 545

Beaver, WV 25813


Phone: 304-894-8721

Fax: 206-984-4613